FVB/N-Tg(Rnu6-RNAi:IE-PRV)SH05Gjo/Orl

Status

Available to order

EMMA IDEM:05365
International strain nameFVB/N-Tg(Rnu6-RNAi:IE-PRV)SH05Gjo/Orl
Alternative nameSH05
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Rnu6-RNAi:IE-PRV)SH05Gjo
Gene/Transgene symbolTg(Rnu6-RNAi:IE-PRV)SH05Gjo

Information from provider

ProviderGenevieve Jolivet
Provider affiliationINRA, INRA
Genetic informationTransgenic mice for a U6-shRNA gene. 4 copies of the transgene are integrated. The U6-shRNA construct encompasses the U6 mouse promoter that drives the transcription of a shRNA expressing transcription unit. The shRNA sequence targets the 3'-part of the intermediate early gene (IE gene) of the Pseudorabies virus (PRV), with the following sequence (5'-CTCCCATCGGGTGAGAAAA-3'). PRV currently infects farm animals (especially pigs) and mice. The U6-shRNA gene is inserted in an empty transgene expression vector encompassing the 5'HS4 insulator from the chicken beta globin gene locus, the human eF1alpha gene promoter (-1430, +2), the rabbit (rb) beta-globin second intron and several enhancers (E1, E2 and E3). The empty expression vector acts as a cargo for the U6-shRNA gene to insure the reliable expression.
Phenotypic informationStable production of siRNA targeting the IE RNA. Resistance to a PRV infection (Bartha strain). No stimulation of the innate immune system in non infected animals.
Breeding historyCurrently bred with wild-type mice. Stable over 5 generations.
References
  • Viral infection resistance conferred on mice by siRNA transgenesis.;Daniel-Carlier Nathalie, Sawafta Ashraf, Passet Bruno, Thépot Dominique, Leroux-Coyau Mathieu, Lefèvre François, Houdebine Louis-Marie, Jolivet Geneviève, ;2013;Transgenic research;22;489-500; 22961198
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous FVB/N, wild-type FVB/N

Literature references

  • Viral infection resistance conferred on mice by siRNA transgenesis.;Daniel-Carlier Nathalie, Sawafta Ashraf, Passet Bruno, Thépot Dominique, Leroux-Coyau Mathieu, Lefèvre François, Houdebine Louis-Marie, Jolivet Geneviève, ;2013;Transgenic research;22;489-500; 22961198

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).